John McGrath, Chief Financial Officer at Atara Biotherapeutics, Inc. (ATRA), sold 5,000 shares at $20.30 ($99K) on 2016-11-10, disclosed to the SEC on 2016-11-14.
Open-market sale of $99k ATRA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.30 | 2,500 | $51K | 51.2% |
| 2 | $19.37 | 2,500 | $48K | 48.8% |
| Total | $19.84 avg | 5,000 | $99K | 100% |
| Filing → |
| ATRA | SELL | 2018-01-12 | $901K | — | Filing → |
| ATRA | SELL | 2018-01-02 | $640K | — | Filing → |
| ATRA | SELL | 2017-08-17 | $60K | — | Filing → |